Cellix is an innovative startup based in Dublin, Ireland, specializing in microfluidics technology. The company develops customized solutions for a variety of industries, including food and beverage, biotechnology, agricultural biotechnology, and personalized medicine. Microfluidics involves manipulating small volumes of fluids to perform various tests and analyses, which is crucial for high-throughput cell analysis and sorting.

Cellix's primary clients are businesses and research institutions in the aforementioned sectors that require precise and efficient cell analysis and sorting capabilities. The company operates in the global biotechnology and healthcare markets, which are rapidly growing due to increasing demand for advanced diagnostic and therapeutic solutions.

The business model of Cellix is built around its strong portfolio of patented technologies. The company generates revenue through intellectual property (IP) licensing, carve-outs (selling parts of its business or technology to other companies), and Original Equipment Manufacturer (OEM) agreements (where Cellix's technology is integrated into products made by other companies).

Cellix's vision is ambitious: to contribute to a future where diseases like cancer can be cured with a simple injection, preventable diseases are eradicated, and global food security is ensured. This vision drives their daily operations and long-term strategy, aiming to position themselves as the leading microfluidics company for high-throughput cell analysis and sorting.

In summary, Cellix is a cutting-edge company leveraging its patented microfluidics technology to serve a diverse range of industries, with a robust business model centered on IP licensing and strategic partnerships.

Keywords: Microfluidics, Biotechnology, Personalized Medicine, Cell Analysis, IP Licensing, High-Throughput, Gene Editing, Food Security, Biotech Solutions, OEM.